Only four patients dropped out of the drug study because of adverse effects. The four events that led to the four people dropping out include loss of concisions, skin rash, suicidal ideations and worsening of depression. Other side effects of vyvnase include diminished appetitive, trouble sleeping, profuse sweating and lethargy.
The company has now submitted its results for an expanded study and hopefully will seek approval by the FDA for treatment of depression.
For the consumer this is good news but one should always be cautious about new drugs. In my opinion when companies perform their own studies, the results are usually positive and negative results are usually hidden. In addition, the study only lasted 9 weeks and it is not known if the positive cognitive function is sustained. Vyvnase is also relatively expensive with each pill costing anywhere from $3-4.
The good news is that most reports from people who take the drug for ADHD are positive.
No comments:
Post a Comment